By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fertility testing firm Celmatix today announced it has secured $1.5 million in additional financing to go toward the expansion of its operations and accelerate a product launch.

The round was led by Topspin Partners. Other investors including Peter Kellner of Richmond Global, Mark Gerson, founder of Gerson Lehrman Group, and Kal Vepuri, founder of the Trisiras Group, also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.